Skip to main content
. 2019 Sep 2;18:168. doi: 10.1186/s12944-019-1103-7

Fig. 7.

Fig. 7

Effect of 4-cholesten-3-one and SR9238 on MCF-7 cells determined by MTT assay. Breast cancer cells were treated for 24 and 48 h with 6.25 μM 4-cholesten-3-one alone, 12.5 μM SR9238 alone, or 6.25 μM 4-cholesten-3-one and 12.5 μM SR9238 together. All data were presented as mean ± standard deviation. *p < 0.05, **p < 0.01, ***p < 0.001